COVID-19 and coagulation parameters: a link to mortality?

The COVID-19 pandemic, caused by SARS-CoV-2, has led to millions of deaths worldwide. Among its major complications is an associated coagulopathy, characterized by hypercoagulation and thromboembolic disorders. These abnormalities, linked to an excessive inflammatory response, manifest as thromboses, pulmonary embolisms, or strokes, and represent a significant factor in the mortality of critically ill patients. This study aimed to establish the association between coagulation parameters and mortality in COVID-19 patients, highlighting potential biomarkers to assess risk and guide clinical care.